Jocelyn Hudson
New data show single-session Indigo aspiration system without overnight thrombolytics is...
During the Society of Interventional Radiology (SIR) 2024 annual meeting (23–28 March, Salt Lake City, USA), newly presented data from a subgroup analysis of...
Endovascular showdown: CX 2024 sets the stage for BASIL-3 first-time data...
At the Charing Cross (CX) Symposium 2024 (23–25 April, London, UK), Andrew Bradbury (University of Birmingham, Birmingham, UK) and the BASIL-3 team of triallists...
Personalized, precision medicine is key to the future of aortic repair
Predicting longevity in patients who may be candidates for aortic repair is challenging. This, coupled with a high and unchanging long-term postoperative mortality rate,...
Hans-Henning Eckstein: 1955–2024
Hans-Henning Eckstein, the vascular surgeon who played a leading role in the SPACE and SPACE 2 randomised controlled trials on the treatment of carotid...
First patient enrolled in IDE study of Aquedeon Medical’s Duett vascular...
Aquedeon Medical has announced the initiation of an investigational device exemption (IDE) clinical trial to study the Duett vascular graft system.
A press release reveals...
US FDA Breakthrough Device designation granted for Biotronik’s Freesolve BTK resorbable...
Biotronik has been granted Breakthrough Device designation (BDD) from the US Food and Drug Administration (FDA) for the Freesolve below-the-knee (BTK) resorbable magnesium scaffold...
Adoption of AI into workflow associated with faster time to assessment...
An abstract presented at the 2024 American Venous Forum (AVF) annual meeting (March 3–6) revealed that, in the treatment of patients with pulmonary embolism...
Frank J. Veith joins ViTAA Medical Solutions’ board of directors
ViTAA Medical Solutions has announced the appointment of Frank J Veith, MD, professor of surgery at the Cleveland Clinic Lerner College of Medicine of...
Endologix initiates postmarket study of the Detour system
Endologix has announced the initiation of the Percutaneous transmural arterial bypass (PTAB)1 postmarket study. This study marks the beginning of a comprehensive postmarket study...
U.S. study highlights racial and ethnic disparities in the placement of...
A nationwide U.S. study, recently published in the Journal of Vascular Surgery: Venous and Lymphatic Disorders (JVS-VL), showed that Black patients had the highest...
Nitinol stents placed in iliac veins “not associated with prolonged back...
In a retrospective review of over 600 patients who underwent iliac vein stent placement, the development of back pain was found to be unrelated...
Consortium led by vascular surgeon-scientist secures $6.4 million funding to develop...
The European Union Horizon Europe, with joint funding from UK Research Innovation, has awarded the NetZeroAICT Consortium €6 million ($6.4 million) in funding to...
AAA and complex repair: ‘We need more evidence,’ says UChicago chief
A randomized controlled trial (RCT) of open repair versus endovascular aneurysm repair (EVAR) for the treatment of abdominal aortic aneurysms (AAAs), as well as...
Could metformin be first-ever medical treatment that is effective at managing...
There is a global interest in assessing whether metformin, which has a long track record of safety and efficacy, is relatively inexpensive and is...
Endospan releases early TRIOMPHE IDE study results at Society of Thoracic...
Endospan shared 30-day results from the first 22 patients enrolled in the TRIOMPHE investigational device exemption (IDE) study in a late-breaking presentation at the...
Gore receives FDA approval for breakthrough endovascular device in complex aortic...
Gore has announced Food and Drug Administration (FDA) approval for the Gore Excluder thoracoabdominal branch endoprosthesis (TAMBE), which the company states is the first...
First patients enrolled in VBX FORWARD clinical study
Gore has announced that the first patients have been enrolled in the Gore VBX FORWARD clinical study, a global prospective, multicenter, randomized controlled trial to compare...
BEST-CLI: A year down the road
A dedicated session at the 2023 VEITHsymposium (Nov. 14–18) in New York City aimed to unpack the ways in which clinical practice and attitudes...
Centers for Medicare & Medicaid Services grants Transitional Pass-Through payment for...
Endologix recently announced that the Centers for Medicare & Medicaid Services (CMS) has granted a Transitional Pass-Through (TPT) payment for the Detour system, effective...
Personalized postoperative anticoagulation needed to curb lower-limb amputations
“We’re going to see more and more amputations if we don’t figure out the right post procedure thromboprophylaxis regime ASAP,” Anahita Dua, MD, warned...
Ego, logistics, money: Overcoming barriers to a successful wound care program
Proper integration of primary care physicians (PCPs) in the multidisciplinary care of vascular wounds is going to play an increasingly important role as the...
Humacyte submits Biologics License Application to FDA seeking approval of Human...
Humacyte today announced that it has submitted a Biologics License Application (BLA) to the Food and Drug Administration (FDA) seeking approval of the Human...
TRANSCEND 36-month data “continue to demonstrate safe and effective performance” of...
Peter Schneider (University of California San Francisco, San Francisco, USA) recently presented 36-month data from Surmodics' TRANSCEND clinical trial at the VEITHsymposium 2023 (14–18...
Twelve-month first-in-human data from Xeltis’ aXess haemodialysis vascular conduit trial presented...
Xeltis has announced "highly encouraging" 12-month results from its first-in-human (FIH) aXess vascular conduit trial. The data were presented by Frans Moll (University Medical...
Randomized trial set to elucidate value of image fusion technology for...
An ongoing UK National Institute for Health and Care Research (NIHR)-funded randomized controlled trial seeks to illuminate the value of an image fusion guidance...
Two-year SWING data ‘continue to show promise’ for sirolimus DCB in...
Two-year data from the SWING trial, a first-in-human study of the safety and performance of the Sundance sirolimus drug-coated balloon (DCB; Surmodics), have been...
NIH-funded research on the use of AI in vascular surgery: A...
Vascular surgeon-scientist Elsie Gyang Ross, MD, recently secured coveted funding through the National Institutes of Health (NIH) Research Project Grant Program (R01)—a rare feat...
PROMISE II 12-month data show durable outcomes with the LimFlow system...
One-year results from the PROMISE II US pivotal trial demonstrate the durability of outcomes of transcatheter arterialisation of the deep veins (TADV) using the...
LimFlow announces agreement to be acquired by Inari Medical
LimFlow announced today that it has entered into a definitive agreement to be acquired by Inari Medical.
A press release details that, under the terms...
CLTI: European cohort study provides ‘strong positive evidence’ for surgery over...
A recently published study has shown that lower limb bypass surgery offered a significantly higher probability of amputation-free survival and wound healing compared with...
Akura thrombectomy system for PE appears safe and demonstrates reduction of...
Results from a first-in-human, prospective, single-arm study of the Akura Medical thrombectomy system (Akura Medical) for pulmonary embolism (PE) were revealed this week at...
One-year CLOUT data demonstrate low rate of PTS following treatment with...
David Dexter (Sentara Vascular Specialists, Norfolk, USA) shared one-year data from the CLOUT registry this week at The VEINS 2023 (28–30 October, Las Vegas,...
REAL-PE demonstrates statistically significant lower major bleeding rates with Ekos system...
Data from the REAL-PE study were presented this week at TCT 2023 (23–26 October, San Francisco, USA) demonstrating that patients treated for pulmonary embolism...
Thrombolex announces new insights from the RESCUE trial with the Bashir...
Thrombolex has announced never-before-reported major reductions in obstruction in all of the segmental pulmonary arteries (PA), based on independent core lab data analysis of...
TCT 2023: LIFE-BTK breathes life into drug-eluting resorbable scaffolds in breakthrough...
Results of the LIFE-BTK randomized controlled trial have just been presented at TCT 2023 (Oct. 23–26) in San Francisco. The data show that, in...
TCT 2023: First presentation of complete patient-level dataset on paclitaxel and...
Data from a patient-level meta-analysis—a factor in the Food and Drug Administration’s (FDA) recent change of position on the use of paclitaxel-coated devices to...
Survey suggests venous work less valued than arterial interventions
The majority of more than 300 vascular surgeons who responded to a recent survey indicated that they perceive the management of venous disease to...
Enrollment of first patient in Neuroguard carotid stent system trial announced
Contego Medical has announced enrollment of the first patient in the prospective, multicenter PERFORMANCE III trial aimed at further evaluating the safety and effectiveness of the...
Obituary: Roger M. Greenhalgh (Feb. 6, 1941–Oct. 6, 2023)
Roger Malcolm Greenhalgh, MD, the surgeon internationally renowned for his unparalleled contribution to vascular education, training and research, died peacefully on Oct. 6. He...
Humacyte announces positive top line results from Phase 2/3 trial of...
Humacyte has announced positive top line results from its V005 Phase 2/3 trial of the Human Acellular Vessel (HAV) in vascular trauma repair.
A...
FDA approves LimFlow system for ‘no-option’ CLTI patients
The Food and Drug Administration (FDA) today announced approval of LimFlow therapy—a novel and minimally invasive procedure designed to bypass blockages in arteries of...
FDA clears AAA-SHAPE trial for IDE approval
Shape Memory Medical recently announced that the Food and Drug Administration (FDA) has granted investigational device exemption (IDE) for the company to begin a...
Multi-society guidelines on varicose vein management published
The Society for Vascular Surgery (SVS), American Venous Forum (AVF), and American Vein and Lymphatic Society (AVLS) have released the second and final part...
Child-bearing age ‘should not be a contraindication to venous stenting’
In a recently published study, dedicated venous stents performed well through pregnancy and postpartum, and a protocol including the use of low-dose antiplatelets in...
Study finds no correlation between IVC filter placement position and device...
Researchers report that inferior vena cava (IVC) filter placement position relative to the level of the most inferior renal vein was not associated with...
SVS responds to CMS proposed coverage expansion for carotid stenting
The Society for Vascular Surgery (SVS) and its affiliated Patient Safety Organization (PSO)/Vascular Quality Initiative (VQI) have submitted a formal response to the Centers...
Humacyte completes enrolment in Phase II/III trial of Human Acellular Vessel...
Humacyte today announced completion of enrollment in its Phase II/III vascular trauma trial (V005) that is expected to support a Biologics License Application (BLA)...
Humacyte completes enrolment in Phase II/III trial of Human Acellular Vessel...
Humacyte today announced completion of enrolment in its Phase II/III vascular trauma trial (V005) that is expected to support a Biologics License Application (BLA)...
Nectero Medical receives FDA clearance of IND application to initiate Phase...
Nectero Medical today announced that the US Food and Drug Administration (FDA) has granted investigational new drug (IND) clearance for the company to initiate...
Study finds similar rates of VTE in both flying and non-flying...
Uncertainty underlying the magnitude of risk posed by long distance air travel in venous thromboembolism (VTE) patients has created the need for a deeper,...
Long-awaited FDA update finds data do not support excess mortality risk...
In a letter to healthcare providers dated July 11, 2023, the Food and Drug Administration (FDA) communicates that the risk of mortality associated with...
VAM 2023 attendees have their say on the impact of BEST-CLI...
As the vascular community continues to unpack the key learnings from two of the biggest trials to date in chronic limb threatening ischemia—BEST-CLI and...
New analysis probes BEST-CLI trial against real-world setting data
A new analysis of chronic limb-threatening ischemia (CLTI) treatment outcomes was presented at the Society for Cardiovascular Angiography & Interventions (SCAI) 2023 Scientific Sessions...
Primary patency after venous stenting best in NIVL patients, study finds
A recent study concludes that non-thrombotic iliac vein lesion (NIVL) patients have better primary patency after venous stenting than patients with venous thrombotic disorders....
Physical pain a risk factor for vascular surgery trainee burnout, survey...
A recent survey has indicated that physical pain is “prevalent” among vascular surgery trainees and represents a risk factor for burnout. Eric Pillado, MD,...
Frailty status beats WIfI score as mortality predictor in all-comer CLTI...
A study presented during Plenary Session 3 at last week’s Vascular Annual Meeting (VAM), concluded that the Wound, Ischemia, and Foot Infection (WIfI) stage...
‘Vigilant’ surveillance and low threshold for further interventions ‘crucial’ following rescue...
The findings of a recent study on reinterventions and sac dynamics after fenestrated endovascular aneurysm repair (FEVAR) with a physician-modified endograft (PMEG) for index...
Future research needed to ‘optimize’ use of imaging technologies during aortic...
Imaging technologies in the aortic space will be a key feature of Saturday’s Plenary Session 8 (11:15 a.m. to 12:30 p.m.) in Potomac A/B,...
Special VAM session underscores ‘complementary’ nature of open and endovascular strategies...
A dedicated session at VAM 2023 saw speakers and delegates gather to debate, analyse and consider the implementation of the BEST-CLI and BASIL-2 randomized-controlled...
Presidential address: ‘The annual meeting is only part of our story’
Friday morning will see Michael C. Dalsing, MD, MBA, deliver what is an annual hallmark of the VAM program—the SVS Presidential Address.
From 11:00 a.m.–12:15...
The global burden of CLTI: ESVS President points toward need for...
Early-bird VAM 2023 attendees yesterday gained broad insight into the issues facing vascular surgeons around the world, with the tone set from the opening...
SVS-VESS@VAM 2023: Observational study addresses ‘ongoing debate’ around intervention in asymptomatic...
Alessandro Gregio, MD, a vascular surgery trainee at the University of Bologna in Bologna, Italy, presented midterm results from the Carotid asymptomatic stenosis observational...
Study weighs up total transfemoral and upper extremity approaches for F/BEVAR
In a prospective, non-randomized study, researchers found that a total transfemoral approach was associated with lower rates of cerebrovascular events and improved outcomes compared...
Endothelial cell granted superhero status in invited research presentation
“The endothelial cell is the superhero of the vascular system,” Kathryn L. Howe, MD, PhD, FRSCS, a vascular surgeon-scientist at the University of Toronto...
Base revascularization strategy on effectiveness in restoring adequate and durable limb...
The results of a subanalysis of the BEST-CLI trial found that patients with chronic limb-threatening ischemia (CLTI) who were deemed suitable for open lower-extremity...
Global perspectives take center stage in second annual WFVS session at...
“The intellectual exchange of information and a better understanding of unique global perspectives has brought the leading societies closer,” Palma Shaw, MD, MBA, secretary...
Urban residents have smaller risk of mortality from chronic limb-threatening ischemia
A new study using data from millions of patients hospitalized across the U.S. has determined whether population density and associated urban versus suburban versus...
Insights from largest chronic limb-threatening ischaemia study to inform quality of...
Data from a cohort of one million patients with chronic limb-threatening ischaemia (CLTI) were recently presented as late-breaking clinical research at the Society for Cardiovascular...
Medical therapy gains highlight need to reassess carotid surgery
“The time has definitely come to look at the evidence, and redo these studies,” posited Alun Davies, MD, from Imperial College London in London,...
Five-year results of the LEOPARD trial published in the Journal of...
Endologix has announced the online publication of the final five-year results of the LEOPARD trial in the Journal of Vascular Surgery (JVS). The study's...
CX 2023: Statins save lives after aortic repair regardless of dose
Statin treatment after aortic repair is associated with improved long-term survival, while dose does not matter. This was the key message from a first-to-podium...
New analysis of chronic limb-threatening ischaemia patients places BEST-CLI trial into...
A new analysis of chronic limb-threatening ischaemia (CLTI) treatment outcomes was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography &...
Reinterventions after physician-modified endovascular grafts ‘non-detrimental’ to long-term survival
For the treatment of juxtarenal aortic aneurysms, reinterventions after physician-modified endovascular grafts (PMEGs) are non-detrimental to long-term survival. This is one of the main...
Study finds no correlation between TEVAR timing and uncomplicated type B...
With proper patient selection, short-term outcomes of thoracic endovascular aortic repair (TEVAR) in acute uncomplicated acute type B aortic dissection (uTBAD) are similar irrespective...
Efforts to move towards routine patch closure or eversion endarterectomy among...
A nationwide cohort study of over 9,000 patients shows that the “controversial” practice of arteriotomy closure for carotid endarterectomy (CEA) is associated with an...
Primary patency after venous stenting best in NIVL patients, study finds
A recent study concludes that non-thrombotic iliac vein lesion (NIVL) patients have better primary patency after venous stenting than patients with venous thrombotic disorders....
FDA approves dissection and transection indication expansion for RelayPro stent graft...
Terumo Aortic announced that the Food and Drug Administration (FDA) has granted approval of the RelayPro thoracic stent graft device for the treatment of...
BASIL-2 points towards endovascular-first revascularization strategy in CLTI patients
A question from Manj Gohel, MD, from Cambridge University Hospitals in Cambridge, England, on what the 2023 Charing Cross (CX) International Symposium audience should...
First implant of custom-made thoracoabdominal hybrid device in North America announced
Terumo Aortic announced the first North American implant of a custom-made hybrid device, Thoracoflo.
A press release noted that the device is used to treat...
Surmodics announces successful first patient use of Sublime radial access microcatheter
Surmodics has announced that Ankur Lodha, MD, an interventional cardiologist at the Cardiovascular Institute of the South in Lafayette, Lousiana, and Pradeep Nair, director...
On 45th anniversary, CX Symposium chairman credits Chicago vascular surgical tandem...
The occasion of a seminal meeting held in Chicago by former Society for Vascular Surgery (SVS) Presidents John J. Bergan, MD, and James S.T....
SVS Vascular Quality Initiative passes milestone 1,000th-center mark
The Society for Vascular Surgery Vascular Quality Initiative (SVS VQI) clinical registry recently announced it has achieved another milestone, with more than 1,000 centers...
Study highlights need for ‘continuous comparative assessments’ to guide endograft treatment...
A recent study comparing outcomes of endovascular aneurysm repair (EVAR) patients has reported no statistically significant differences in mortality or secondary rupture rates between...
STEVECO trial calls into question randomization in the venous stenting field
Recruitment proved to be a major challenge for the STEVECO (Stent versus conservative treatment in patients with deep venous obstruction) randomized controlled trial (RCT),...
Viz.ai receives FDA 510(k) clearance for abdominal aortic aneurysm AI algorithm
Viz.ai recently announced it has received Food and Drug Administration (FDA) 510(k) clearance for its algorithm intended to detect suspected abdominal aortic aneurysm (AAA)....
Vesteck completes first-in-human use of several Suture-Tight devices
Vesteck scientific advisory board members along with key opinion leaders from around the world have successfully completed the first three in-human cases with the...
Algorithm predicts females have higher risk for kidney damage after aneurysm...
When receiving treatment for abdominal aortic aneurysm (AAA), female patients have a higher risk for kidney damage after endovascular repair, a Michigan Medicine study...
New VOYAGER PAD analysis confirms consistent benefit of low-dose rivaroxaban plus...
Data from a new prespecified analysis of the phase III VOYAGER PAD clinical trial show that low-dose rivaroxaban plus aspirin resulted in a 33%...
‘Urgent action needed’ to improve implementation of guideline-directed medical therapy for...
Almost one-half of the patients receiving a peripheral vascular intervention (PVI) in the Society for Vascular Surgery (SVS) Vascular Quality Initiative (VQI) registry between...
BioGenCell begins recruitment for clinical trial of stem cell-based treatment for...
BioGenCell has announced that it is recruiting for an international clinical trial to assess the company's stem cell-based therapy for chronic limb-threatening ischemia patients...
Biotronik launches Oscar multifunctional peripheral catheter
Biotronik has announced the Food and Drug Administration (FDA) 510(k) clearance and CE mark of its Oscar (One Solution: Cross. Adjust. Restore) multifunctional peripheral...
Educate, educate, and educate again: The continuing quest for appropriate venous...
Prominent venous disease experts discuss venous stenting, appropriate care, and the pursuit of refined data and better education in a space where part of...
VQI study leader highlights virtue of multispecialty gathering of best longitudinal...
Daniel Bertges, MD, talks to Vascular Specialist about recent findings from his work investigating the IN.PACT Admiral drug-coated balloon (DCB). He related how they...
PRELUDE-BTK subanalysis highlights superior lumen gain, greater volumetric blood flow using...
Cagent Vascular has announced the results of a comparative subanalysis of the PRELUDE-below-the-knee (BTK) study versus plain balloon angioplasty.
The study was led by Marianne...
Surmodics provides regulatory update related to FDA premarket approval application for...
Surmodics recently announced it has received a letter from the Food and Drug Administration (FDA) related to its premarket approval (PMA) application for the...
Viz.ai launches AI-powered Viz Vascular Suite
Viz.ai has announced the launch of Viz Vascular Suite—artificial intelligence (AI)-powered software enabling vascular care teams to automatically detect and triage care for suspected pulmonary...
ESVS AAA guidelines alert recommends ‘enhanced surveillance’ in patients treated with...
In a newly released “focused update” to their 2019 recommendations, the European Society for Vascular Surgery (ESVS) abdominal aortic aneurysm (AAA) guidelines writing committee...
Paclitaxel DCB performs well in ‘challenging anatomy’ of femoropopliteal in-stent restenosis,...
The IN.PACT Admiral drug-coated balloon (DCB) shows promising results in treating femoropopliteal in-stent restenosis (ISR) in a Society for Vascular Surgery (SVS) Vascular Quality...
NESVS 2022 Presidential Address: ‘We can create a bold new future...
“Collaborate, innovate, mentor, champion DEI and relish the opportunity to form deep connections with our amazing patients.” This was the key take-home message...
First-in-human patients continue to benefit from VenoValve at average of three...
Positive long-term, three-year observational data from a cohort of patients that participated in the previously concluded VenoValve (Envveno Medical) first-in-human clinical trial were recently...
SWING trial 12-month data: Novel sirolimus DCB shows ‘great promise’ in...
The Sundance (Surmodics) sirolimus drug-coated balloon (DCB) has an “excellent” safety profile in a “challenging, real-world, predominantly CLTI population,” and has a primary...
VEITHsymposium panel probes ‘value’ of artificial intelligence in vascular surgery
A session at the 2022 VEITHsymposium in New York City (Nov. 15–19) focused on new concepts, machine learning, and artificial intelligence (AI) in vascular...
First data from BEST-CLI bring surgical bypass into the forefront of...
The first results from the BEST-CLI randomized controlled trial (RCT) of 1,830 patients show that surgical bypass with adequate single-segment great saphenous vein (GSV)...
‘Significant’ increase in atherectomy use in US largely driven by office-based...
In the United States, atherectomy use in peripheral vascular interventions (PVIs) “more than doubled” from 2010 to 2019, with office-based procedures a “major driver”...
Disrupt PAD III observational study results confirm safety and effectiveness of...
The final 1,373-patient cohort analysis from the Disrupt PAD III observational study (OS) demonstrates consistent intravascular lithotripsy (IVL; Shockwave Medical) outcomes in complex and...
SurVeil DCB demonstrates sustained durability of safety, efficacy endpoints in TRANSCEND
In the TRANSCEND clinical trial, the SurVeil drug-coated balloon (DCB; Surmodics) demonstrated "excellent efficacy and safety" out to 24-month follow-up. This is according to...
‘Excellent’ three-year results presented for the BioMimics 3D stent in longer...
At the 2022 Vascular Interventional Advances (VIVA) meeting (Oct. 31–3 Nov. 3), Michael Lichtenberg, MD, from Arnsberg Clinic, Arnsberg, Germany, reported a subgroup analysis...
Mechanical thrombectomy for DVT: Randomized data needed to boost growing evidence...
Two datasets presented during the late-breaking clinical trials session at The VEINS (Venous Endovascular Interventional Strategies) 2022 (Oct. 30–31) in Las Vegas—the latest results...
CX Aortic Vienna: Onus on industry to meet clinician desire for...
The need for vascular companies to home in on developing longer-lasting devices—perhaps even ones that adapt over time to match patients’ changing anatomies—was underscored...
Mortality drops for acute type A aortic dissection, still high for...
The chance of a patient surviving after an acute type A aortic dissection has improved significantly, but mortality remains high if not recognized early and repaired...
Ukrainian surgeons present clinical update on Human Acellular Vessel in vascular...
Humacyte recently announced the presentation of a clinical update on the Human Acellular Vessel (HAV) for the treatment of vascular trauma. The update was...
ESVS publishes ‘pioneering’ clinical practice guidelines on radiation safety
The European Society for Vascular Surgery (ESVS) has released clinical practice guidelines on radiation safety, which the writing committee notes are the first guidelines...
Experts establish international standard set of outcome measures for patients with...
The International Consortium for Health Outcomes Measurement (ICHOM) venous thromboembolism (VTE) working group has developed a standard set of outcome measures for patients with...
Society for Vascular Surgery Vascular Quality Initiative celebrates one million procedures
The Society for Vascular Surgery Vascular Quality Initiative (SVS VQI) clinical registry announced this week it has now collected more than one million procedures...
WARRIORS randomized trial aims to examine early EVAR in women
This month a multinational collaboration of researchers received endorsement from the Global Cardiovascular Research Funders Forum (GCRFF) Multinational Clinical Trials Initiative for the WARRIORS...
Trial supports full-dose anticoagulation to prevent blood clots in COVID-19 patients
Treatment of critically ill COVID-19 patients with full-dose anticoagulation lowers the risk of venous and arterial clotting complications by 44% compared with the standard dose, according to late...
Researchers study role of frailty in post-discharge mortality
Society for Vascular Surgery (SVS) members have developed new methods and tools to assess patient frailty and possible surgical outcomes more simply before patients...
Retrospective study is ‘first to systematically explore predictors of venous stent...
New data indicate that venous stent failure “may be predicted by low peak flow velocity and post-thrombotic changes in inflow veins” and that endovascular venous...
Study is first to elucidate lower-limb amputation epidemiology in a Latin...
A study recently published in the World Journal of Surgery claims to be the first to provide comprehensive population-level data on the epidemiology of lower-extremity...
Key differences in presentation, outcomes for distal versus proximal DVT uncovered
A new study highlights key differences in clinical features and comorbidities, as well as short-term and also long-term outcomes for patients with distal deep...
Selution SLR receives second FDA IDE approval
Selution SLR, MedAlliance’s sirolimus-eluting balloon, has received conditional Food and Drug Administration (FDA) investigational device exemption (IDE) approval to initiate its pivotal clinical trial...
JACC study makes case for expanding coverage for carotid artery stenting
Research from Ochsner Health published in the Journal of the American College of Cardiology (JACC) is likely to influence expanded insurance coverage for carotid artery stenting.
The...
Compression duration affects pain during superficial venous intervention, study finds
Postprocedural compression of one to two weeks after superficial venous incompetence (SVI) treatment is associated with reduced pain compared with a shorter duration. This...
Enrollment begins in PERSEVERE clinical trial of hybrid prothesis for aortic...
Artivion announced today that it has initiated enrollment in the PERSEVERE clinical trial to determine if patients with an acute DeBakey Type I aortic dissection...
Intraoperative vascular mapping during hemodialysis access ‘should be incorporated into routine...
Intraoperative ultrasonographic venous mapping is a useful tool to evaluate vessel suitability for arteriovenous fistula (AVF) creation, Yana Etkin, MD, associate professor of surgery...
Female sex is associated with reintervention and mortality following elective EVAR
Women are more likely to die within five years of having elective surgery to repair an abdominal aortic aneurysm (AAA) or need repeat surgery, according to...
Female sex is associated with additional treatments following surgery for intermittent...
A new U.S. study has found that female sex is associated with more reinterventions after surgical treatment for intermittent claudication. Additionally, guideline-directed medical therapy,...
Cordis announces start of enrollment in RADIANCY clinical study in Europe
Cordis has announced the start of the European RADIANCY premarket clinical study of a stent system designed for radial access in the treatment of...
PAD: Ra Medical Systems receives FDA 510(k) clearance for the Dabra...
Ra Medical Systems has announced receipt of Food and Drug Administration (FDA) 510(k) clearance for the company’s Dabra 2.0 catheter as part of the...
ALI can occur with or without atherosclerotic disease, portends worse prognosis...
Acute limb ischemia (ALI) can occur with or without atherosclerotic disease and portends a worse prognosis in patients with COVID-19. This risk persists after...
New findings support benefits of structured discharge approach for post-discharge transition...
Researchers have found that restructuring the discharge process of a vascular surgery service decreased escalation to clinical staff from an automated post-discharge phone call...
Study demonstrates feasibility, effectiveness of at-home exercise therapy plus cognitive behavior...
A mobile phone-administered, home-based exercise therapy program for patients with intermittent claudication (IC) incorporating cognitive behavior therapy (CBT) was found to be feasible, with...
Humacyte provides update on patients treated at front-line hospitals in Ukraine...
Humacyte today announced that the first Ukrainian patients have received implants of the Human Acellular Vessel (HAV) for the treatment of vascular trauma injuries....
Iliac vein stenting should remain a viable treatment option for higher...
Despite greater comorbid conditions, patients with obesity benefited as much as patients with normal body mass index (BMI) from iliac vein stent placement for...
Researchers report higher three-year amputation and reintervention rates in Black and...
In a study of over 7,000 chronic limb-threatening ischemia (CLTI) patients, researchers found that Black and Hispanic patients had higher three-year amputation and reintervention...
Wound healing research earns SVS Foundation prize, place on VAM stage
University of Michigan resident and Vascular Specialist resident/fellow editor Christopher Audu, MD, has been granted the SVS Foundation Resident Research Award for 2022. And,...
Early TCAR results in higher ipsilateral postoperative stroke rates when compared...
Adham Elmously, MD, a fellow at New York Presbyterian Hospital, New York, is set to present outcomes of early transcarotid artery revascularization (TCAR) vs....
New data support covered stent use in complex aortoiliac occlusive disease...
One-year outcomes from the BELSTREAM trial add to a growing pool of data that covered stents are safe and effective in the treatment of...
Revascularization strategy for BTK intervention should hinge on diagnostic modality, LINC...
New data provide “another argument” for the use of intravascular ultrasound (IVUS) in below-the-knee (BTK) interventions. This is according to Michael Lichtenberg, MD, from Arnsberg...
Research indicates low stroke risk and benefit of medication alone in...
The risk of having a future stroke caused by asymptomatic carotid stenosis is “so low” that most patients with this condition could potentially be treated with...
Non-optimal therapy for CLTI ‘more prominent in females’
A real-world claims data analysis of nearly 200,000 patients with chronic limb-threatening ischemia (CLTI) showed that female patients were older, underwent vascular procedures less often, and...
Cancer patients face greater risks from AAA repair
Elective abdominal aortic aneurysm (AAA) repair in patients with a cancer diagnosis is associated with several poor postoperative outcomes, according to a newly published study from researchers...
Less frequent post-EVAR surveillance might be safe in some patient groups,...
Results from the multicenter, retrospective ODYSSEUS study carried out in The Netherlands suggest that less frequent surveillance after endovascular aneurysm repair (EVAR) may be...
Artificial intelligence could make endovascular aortic repair outcomes more predictable, CX...
At the 2022 Charing Cross (CX) International Symposium (April 26–28) in London, England, Tom Carrell, MD, a vascular surgeon in Cambridge, England, and founder of...
SCAI releases multi-society position statement focused on core competencies for endovascular...
The Society for Cardiovascular Angiography & Interventions (SCAI) has released a position statement outlining competencies for endovascular specialists who provide care for chronic limb-threatening...
Alucent Biomedical announces first patient enrolled in first-in-human natural vascular scaffolding...
Alucent Biomedical announced in a press release that it has enrolled the first patient in ACTIVATE II, an Australia-based first-in-human clinical trial to evaluate the...
Shockwave Medical announces global launch of new peripheral IVL catheter
Shockwave Medical has announced the global commercial availability of the Shockwave M5+ peripheral intravascular lithotripsy (IVL) catheter after receiving both Food and Drug Administration (FDA) and...
Medtronic issues voluntary recall for subset of IN.PACT Admiral and IN.PACT...
Medtronic recently voluntarily recalled a subset of its IN.PACT Admiral and IN.PACT AV paclitaxel-coated percutaneous transluminal angioplasty (PTA) balloon catheters due to the potential...
Randomized trial suggests carotid endarterectomy does not affect dementia risk
Carotid endarterectomy (CEA) does not appear to either reduce or increase the risk of dementia, despite it having been shown to reduce stroke risk....
F/BEVAR review reveals less than 20% of patients suffered intraoperative adverse...
A retrospective evaluation of 600 fenestrated or branched endovascular aneurysm repairs (F/BEVARs) for the treatment of complex aneurysms revealed that fewer than one in...
Dedicated vs. non-dedicated: Researchers place venous stenting under the spotlight at...
Venous stenting was a hot topic on the agenda of the recent American Venous Forum (AVF) annual meeting, held this year Feb. 23–26 in Orlando,...
Viabahn use in claudicants with long, complex SFA lesions ‘safe and...
Recently published research indicates that stent grafting with the Viabahn endoprosthesis (W L Gore & Associates) of long and complex superficial femoral artery (SFA) lesions in...
Writing and reviewing in the DEI space: Progress evident but ‘there’s...
It’s been more than 18 months since the Journal of Vascular Surgery (JVS) implemented changes aimed in part at diversifying involvement with the publication...
FDA advisory panel issues recommendations on lifelong surveillance for EVAR
The Food and Drug Administration (FDA) recently announced it has issued a letter to healthcare providers emphasizing the importance of lifelong surveillance, including imaging,...
Study ‘supports’ SVS open AAA volume recommendations
A multicenter, retrospective database analysis suggests improved open abdominal aortic aneurysm (AAA) outcomes when surgeon volume is greater than seven cases yearly and performed in...
Worldwide TCAR analysis provides ‘roadmap’ to evaluate future training approaches
An analysis of the worldwide experience of transcarotid artery revascularization (TCAR) has produced key objective proficiency metrics and an analytic framework to assess adequate...
Study highlights need to extend scope of cerebrovascular health disparities research
A new research letter in Stroke outlines use of the novel National Institutes of Health (NIH) All of Us research program dataset of diverse...
Medtronic issues voluntary recall for TurboHawk Plus directional atherectomy system
On Feb. 7, Medtronic issued a notice emphasizing that the same warnings and precautions issued for the HawkOne directional atherectomy system also apply for...
Risk of venous stent migration ‘rare’ but probably ‘underreported,’ systematic review...
Stent migration following treatment of acute iliofemoral thrombus or venous obstruction is “rare but may be underreported,” with the majority of reported cases being...
WFVS seeks to help shape future of global vascular training through...
The World Federation of Vascular Societies (WFVS) recently entered a new era of governance with the aim of better disseminating science and best practices...
Cook Medical receives FDA breakthrough designation for new drug-eluting stent
Cook Medical has received Breakthrough Device designation from the Food and Drug Administration (FDA) on a new drug-eluting stent (DES) for below the knee...
Thrombolex: Investigational RESCUE trial yields ‘exciting’ interim data
The prespecified interim analysis of the first 62 evaluable pulmonary embolism (PE) patients enrolled in the investigational RESCUE trial produced positive results, Thrombolex has...
Philips integrates cloud-based AI and 3D mapping into its mobile C-arm...
Royal Philips has announced physicians will now have access to advanced new 3D image guidance capabilities through its image-guided therapy mobile C-arm system—Zenition. The...
ISET 2022 audience hears latest data on endovascular therapies
At this year’s International Symposium on Endovascular Therapy (ISET), being held Jan. 16–19 in Hollywood, Florida, experts presented an array of late-breaking trial results...
CSI announces development of IVL technology for the treatment of PAD
Cardiovascular Systems (CSI) recently announced that it has made significant progress towards the commercialization of its intravascular lithotripsy (IVL) system for the treatment of...
Europe: ESVS publishes 2022 guidelines on management of chronic venous disease...
The European Society for Vascular Surgery (ESVS) has released 2022 clinical practice guidelines on the management of chronic venous disease (CVD) of the lower...
New recommendations promote ‘appropriate and effective’ use of social media in...
In response to a rapid augmentation of social media use in medicine over the past five years, the Society for Vascular Surgery (SVS) has...
US IDE Aortic Research Consortium ‘pushes the envelope’ on F/BEVAR
The U.S. investigational device exemption (IDE) Aortic Research Consortium has produced the strongest data so far on the use of fenestrated/branched endovascular aneurysm repair...
FDA issues updated safety communication on use of Endologix AFX endovascular...
The Food and Drug Administration (FDA) has issued an updated safety communication on the use of Endologix AFX endovascular grafts. This update includes...
FDA approves two pediatric venous thromboembolism indications for rivaroxaban
The Food and Drug Administration (FDA) has approved two pediatric indications for Xarelto (rivaroxaban): the treatment of venous thromboembolism (VTE) and reduction in the risk of recurrent...
TCAR affords greater quality-adjusted life years than carotid endarterectomy, cost-effectiveness model...
A cost-effectiveness model based on peer-reviewed sources suggests that although five-year costs for transcarotid artery revascularization (TCAR) were higher than those for carotid endarterectomy (CEA), TCAR afforded...
World in motion: WFVS seeks to help shape future of global...
The World Federation of Vascular Societies (WFVS) recently entered a new era of governance with the aim of better disseminating science and best practices...
Collaborative effort key to investigating potential biomarker of acute aortic syndrome
Research indicates that plasma desmosine has the potential to act as a biomarker of acute aortic syndrome and could, in the future, be used as a...
Surgeons must stay skilled in femorotibial/pedal bypass surgery, Paris audience hears
At Paris Vascular Insights (PVI) 2021 (Oct. 21–23, Paris, France), Peter Schneider, MD, University of California San Francisco, San Francisco, emphasized the need for...
New ACS president aims to sow seeds of hope for enhanced...
Former Society for Vascular Surgery (SVS) President Julie A. Freischlag recently took over the presidential reins of the American College of Surgeons (ACS). Here...
Clinical evaluation of robotic-assisted peripheral artery intervention in human completed
Aopeng Medical’s Allvas endovascular intervention surgical robot has successfully carried out a first-in-human clinical evaluation of a robot-assisted peripheral artery intervention of an iliac...
Endologix announces completion of enrollment in TORUS 2 study for PAD...
Endologix has completed enrollment in the TORUS 2 investigational device exemption (IDE) clinical study in the U.S., a press release reports.
The TORUS 2 study...
First patient enrolled in Disrupt BTK II study for long, calcified,...
Shockwave Medical has announced the start of the Disrupt BTK II postmarket study to assess the safety, effectiveness and optimal clinical use of the Shockwave...
Hispanic adults with PAD access inpatient care most often via the...
Hispanic adults hospitalized for treatment of symptoms of peripheral arterial disease (PAD) were more likely to access this care by going to the emergency...
Researchers develop ‘world’s first’ smart bandage that detects multiple biomarkers for...
A research team led by Lim Chwee Teck, PhD, from the National University of Singapore’s (NUS) Department of Biomedical Engineering and Institute for Health...
WIfI system helps predict revascularization benefit for diabetic patients with CLTI,...
A retrospective study supports the use of the Wound, ischemia, and foot infection (WIfI) classification system to predict the revascularization benefit for diabetic patients with chronic limb-threatening ischemia...
Sanford invents Breakthrough Device for TAAA
An investigational device invented at Sanford Health in Sioux Falls, South Dakota, that helps high-risk vascular disease patients has been granted a Breakthrough Device...
PROMISE I 24-month results ‘validate the benefits of the LimFlow system’
LimFlow has announced 24-month results from the PROMISE I study of the LimFlow percutaneous deep vein arterialization system, confirming “excellent and sustained outcomes” for...
Physicians, industry urged to tackle multifactorial stroke risk following thoracic endovascular...
As evidence builds on the importance of reducing the risk of stroke by removing residual air prior to thoracic endovascular aortic repair (TEVAR) procedures,...
Survey on radiation safety in vascular trainees demonstrates a quarter received...
A collaborative effort is needed to establish and adhere to best practice guidelines for radiation safety and exposure, Jasmine Bhinder, MD, a general surgery...
New imaging technique has potential to identify patients at high risk...
Four-dimensional (4D) flow magnetic resonance imaging (MRI) has the potential to identify patients with a higher risk of severe complications from aortic degeneration, according...
Thirty-year experience indicates SMA aneurysms are ‘relatively stable’
Based on 30 years of experience, researchers have concluded that aneurysms of the superior mesenteric artery (SMA) are “relatively stable” and that those <20mm...
Five-year ACST-2 results: Carotid artery surgery and stenting have similar long-term...
Carotid artery surgery and stenting have comparable long-term effects on fatal or disabling stroke in asymptomatic patients with severe carotid artery stenosis. That is the finding of...
Females were 30% less likely to undergo surgery for PAD, national...
A review of more than 1 million patients receiving vascular surgery over a 16-year period identified significant sex-related disparities in the treatment of abdominal...
Amputation rates higher for people with PAD who are poor or...
Poverty and Black race were associated with higher rates of lower-leg amputation among people with peripheral arterial disease (PAD) who live in metropolitan areas, according to new...
First patient enrolled in AAA-SHAPE Netherlands study
Shape Memory Medical has announced the initiation of AAA-SHAPE Netherlands, the company’s prospective, multicenter early feasibility study of the Impede-FX RapidFill device when used...
FDA approves expanded PAD indication for rivaroxaban plus aspirin
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Food and Drug Administration (FDA) has approved an expanded peripheral arterial disease...
Fist Assist device achieves significant perforator vein dilation for improved endoAVF...
Fist Assist Devices has announced that data associated with the p-FACT cohort, a subset of the recently completed, non-significant risk Fist Assist clinical trial (FACT...
Research letter highlights low adoption of supervised exercise therapy for PAD
A research letter published in Circulation: Cardiovascular Quality and Outcomes highlights a “very low” utilization of supervised exercise therapy (SET) in symptomatic peripheral arterial disease (PAD) patients...
VOYAGER PAD: Rivaroxaban plus aspirin should be considered after lower-extremity bypass...
“A strategy of adding rivaroxaban 2.5mg twice daily to aspirin should be considered after lower extremity bypass regardless of conduit type,” concluded Nicholas Govsyeyev,...
PRISTINE registry with Selution SLR sirolimus drug-eluting balloon completes enrollment
MedAlliance has announced completion of patient enrollment in the PRISTINE clinical trial with the Selution SLR 018 drug-eluting balloon (DEB) for the treatment of patients with below-the-knee...
AHA publishes updated scientific statement on PAD
The American Heart Association (AHA) has released a new scientific statement on lower extremity peripheral arterial disease (PAD), focusing on contemporary epidemiology, management gaps, and future directions.
The...
SVS publishes DEI supplement to highlight challenges and opportunities within the...
With a firm eye on healing disparities in healthcare and within the vascular surgery specialty itself, the Society for Vascular Surgery (SVS) has published...
SVS releases updated clinical practice guidelines covering carotid disease
The Society for Vascular Surgery (SVS) has released updated clinical practice guidelines accompanied by an implementation document on the management of patients with extracranial...
Large study shows drop in AAA mortality ‘at faster rate than...
According to a new, population-based analysis, abdominal aortic aneurysm (AAA) mortality has continued to decline and “at a faster rate than ever” in the...
Fempop bypass shows reintervention benefit over endovascular therapy for advanced premature...
Femoropopliteal bypass is associated with decreased reinterventions at one year compared to endovascular therapy in patients with advanced premature peripheral arterial disease (PAD). This is...
Philips announces positive two-year data from TOBA II BTK clinical trial
Royal Philips recently announced positive two-year results from the TOBA (Tack optimized balloon angioplasty) II below-the-knee (BTK) clinical trial.
The data show the Philips Tack endovascular...
Boston Scientific and BD initiate venous stent recalls
Boston Scientific and BD have both initiated recalls of venous stents. According to a Food and Drug Administration (FDA) medical device recall notice posted...
Boston Scientific recalls Vici SDS and Vici RDS venous stent systems...
According to a medical device recall notice posted on the Food and Drug Administration (FDA) website, Boston Scientific has recalled its Vici venous stent...
One-year results from PROMISE I study of LimFlow system in ‘no-option’...
Twelve-month data from the full patient cohort in the PROMISE I study of the LimFlow percutaneous deep vein arterialization (pDVA) system have been...
Endologix announces launch of Alto abdominal stent graft in Canada
Endologix today announced the first implant of its Alto abdominal stent graft in Canada following recent approval from Health Canada. Alto was also recently...
‘Radiation will be a thing of the past’
Discussion during the opening day of the Charing Cross (CX) 2021 Digital Edition emphasized the potential of Philips’ Fiber Optic RealShape (FORS) technology to...
BUTTERFLY study finds most reinterventions after FEVAR are not related to...
A mid-term assessment of bridging stentgraft integrity and flare geometry following fenestrated endovascular aortic repair (FEVAR) finds that, although there is a substantial reintervention...
Intravascular shunts improve early limb salvage after extremity vascular injury, study...
A multicenter retrospective study of the PROOVIT (Prospective observational vascular injury treatment) registry suggests the use of temporary intravascular shunts (TIVSs) results in lower...
Added benefit of carotid revascularization to modern medical care ‘needs to...
A pooled meta-analysis found that patients with symptomatic carotid stenosis enrolled in recent randomized controlled trials (RCTs) had a lower risk of stroke after...
Fluoroscopically-guided insertion of td-CVC found to be ‘low exposure,’ despite large...
While there is large variability based on the site of insertion, patient characteristics and previous accesses, fluoroscopically-guided insertion of tunnelled central venous catheters (td-CVC)...
New data support ‘routine’ use of IVUS during iliac vein stenting...
A recent study on iliac vein stenting showed better short and mid-term patency rates when intravascular ultrasound (IVUS) was utilized prior to stent deployment...
US surgeons begin commercial use of Gore Excluder conformable AAA endoprosthesis...
W. L. Gore & Associates (Gore) today announced the first use of the Food and Drug Administration (FDA)-approved Gore Excluder conformable abdominal aortic aneurysm...
Researchers recommend national registries address geographical variation in DVT guideline implementation
A new review concludes that the implementation of clinical guidelines for the management of patients with deep vein thrombosis (DVT) varies among countries, from strict...
Study: ELVeS Radial varicose vein laser therapy shows ‘excellent’ long-term results
Long-term results of patients who underwent outpatient laser treatment for varicose veins at the great saphenous vein (GSV) or small saphenous vein (SSV) in...
British AAA screening results show ‘considerable’ local variation in proportion of...
The first detailed surgical results from the U.K. National Health Service (NHS) Abdominal Aortic Aneurysm Screening Programme (NAAASP) show that, over a seven-year period,...
Hospital availability of TCAR associated with an improvement in overall outcomes...
Silk Road Medical has announced positive results from a comparative-effectiveness study involving transcarotid artery revascularization (TCAR) that was published in JAMA Network Open.
The study...
FDA panel recommends against premarket approval of Lutonix 014 DCB for...
A Food and Drug Administration (FDA) advisory panel has recommended against premarket approval of BD’s Lutonix 014 drug-coated balloon (DCB) for use in below-the-knee (BTK) arteries....
Postmarket study of sirolimus-eluting balloon enrolls first patient
MedAlliance has announced enrollment of the first patient in SUCCESS PTA, its large post-market study with the drug-eluting balloon Selution SLR for the treatment...
Evidence suggests wearable activity monitors could benefit intermittent claudication patients
There is some evidence to indicate that the inclusion of wearable activity monitors in home-based exercise therapy improves walking ability and quality of life...
LINC 2021: Long-term data show sustained efficacy and safety of paclitaxel...
A key theme among the late-breaking trial data presented at the recent LINC 2021 (the Leipzig Interventional Course), held digitally from Jan. 25–29, was the...
Patients with depression ‘less likely’ to go home after CLTI revascularization
A recent analysis established an association between depression and non-home discharge after revascularization for chronic limb-threatening ischemia (CLTI)—providing further evidence, the authors say, that...
Study of patients undergoing AAA repair suggests screening guidelines may be...
A retrospective study analyzing approximately 55,000 patients undergoing abdominal aortic aneurysm (AAA) repair suggests current screening guidelines may be inadequate in detecting a significant...
Total endovascular aortic arch treatment shows promise in dissections, but secondary...
Speaking at the Virtual Aortic Surgery How to Do It Highlights conference (Dec. 17–18), Stéphan Haulon, MD, a vascular surgeon at Hôpital Marie Lannelongue,...
Pre-emptive embolization of aneurysm sac side branches prevents post-EVAR type II...
According to Daniela Branzan, MD, a senior vascular surgeon at University Hospital Leipzig, in Leipzig, Germany, and colleagues, pre-emptive embolization of aneurysm sac side...
Simulation-based training shown to build open vascular surgery skills
A recent systematic review found that “carefully designed and structured” simulation-based training (SBT) in open vascular surgery is effective and can improve technical skills,...
‘Successful’ first-in-human use of the Efemoral scaffold system announced
Efemoral Medical has announced the first-in-human (FIH) use of the company’s Efemoral Vascular scaffold system (EVSS) with FlexStepv technology in the EFEMORAL I FIH...
SWEDEPAD unplanned interim analysis shows no difference in all-cause mortality for...
An unplanned interim analysis of the registry-based SWEDEPAD clinical trial, in which patients with peripheral arterial disease (PAD) received treatment with paclitaxel-coated (drug-coated balloons...
Vesper Medical announces first enrollment in the VIVID trial
Vesper Medical recently announced initiation of its Food and Drug Administration (FDA) investigational device exemption (IDE) study, VIVID (Venous stent for the iliofemoral vein investigational clinical trial...
Risk of ‘feared’ ischemic steal syndrome comparable for tapered and non-tapered...
In a recent systematic review and meta-analysis, Venkata Sai Jasty, from the University of Arizona College of Medicine in Tuscon, Arizona, and colleagues found...
DETOUR I two-year outcomes: ‘Excellent’ functional improvement in complex PAD cohort
During a late-breaking data session at this year’s Vascular Interventional Advances virtual annual meeting (VIVA 2020) Nov 6–8, Ehrin Armstrong, MD, a professor of...
Intravascular lithotripsy ‘superior’ to PTA in acute procedural success out to...
The DISRUPT PAD III randomized controlled trial (RCT) provides the largest level-one evidence for the treatment of heavily calcified femoropopliteal arteries, noted William Gray,...
Latest VOYAGER PAD analysis finds no mortality and improved limb outcomes...
Given the absence of a safety signal in data from the VOYAGER PAD trial, a new analysis examined the potential benefit of drug-coated device...
Janssen applies to FDA for new indication to expand use of...
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it has submitted a supplemental New Drug Application (sNDA) to the Food and Drug...
TCT 2020 late-breaking trials session features new data on drug-coated devices
Findings from a series of late-breaking trials in the endovascular field were delivered recently at TCT Connect (Oct. 14–18), the 32nd annual scientific symposium...
SAVE registry finds Surfacer system safe and effective
The Surfacer Inside-Out access catheter system device (Bluegrass Vascular) is safe and effective for patients with thoracic central venous obstruction requiring central venous access....
Study identifies new genetic factors associated with AAA risk
The American Heart Association (AHA) recently announced the publication of a study identifying 14 new genes linked to an increased risk of abdominal aortic...
CX Aortic Vienna reveals preoccupation with radiation reduction, showcases latest CT...
Polling at CX Aortic Vienna points to a high level of vigilance over radiation exposure during endovascular aneurysm repair (EVAR). This was among the...
Ascending aorta: Challenges of obtaining data discussed at CX Aortic Vienna
In the ascending aorta session at CX Aortic Vienna, presentations focused on various treatment options, including frozen elephant trunk (FET) and endovascular intervention. The...
Inaugural CX Aortic Vienna to take place online
The inaugural CX Aortic Vienna meeting will be livestreamed Sept. 8–11 to an international, online audience, and will include registrant participation, interaction and polling.
The...
High level of heterogeneity found in randomized PAD trial antithrombotic regimens
A recent systematic review showed that randomized trials comparing different types of peripheral endovascular arterial intervention have a high level of heterogeneity in their...
Six-month IN.PACT AV Access results show superiority of DCB angioplasty
Just-published six-month results of the IN.PACT AV Access study show that drug-coated balloon (DCB) angioplasty is superior to standard angioplasty for the treatment of...
First patients enrolled in SUPERSURG study of Supera peripheral stent system
ID3 Medical Belgium has announced the first two enrollments in the SUPERSURG study to investigate the safety and efficacy of Abbotts’ Supera peripheral stent...
Regional anesthesia alone is reasonable for lower extremity amputation in high-risk...
A recent study, published online in the European Journal of Vascular and Endovascular Surgery (EJVES), found that regional anesthesia alone is reasonable for major lower extremity...
VQI analysis finds endovascular repair of rAAA superior to open repair
A recent study examining the effect of operative approach on outcomes in patients presenting with ruptured abdominal aortic aneurysm (rAAA) demonstrated clear short- and...
Ultrasound-guided PTA is a ‘valuable tool’ in vascular access stenosis
Routine ultrasound-guided percutaneous transluminal angioplasty (PTA) is a feasible treatment for native arteriovenous fistula (AVF) dysfunction, according to a recent study by Antonio Granata,...
Five-year survival after EVAR for ruptured AAA ‘improving’
“The relative survival benefit of EVAR over open repair has increased over time,” conclude Rens R.B. Varkevisser, BS, of Beth Israel Deaconess Medical Center,...
JVS study shows advantages of Ellipsys system in dialysis access creation
A new study shows significant benefits of the Ellipsys vascular access system (Avenu Medical) in easily and safely creating durable vascular access for end-stage...
Surfacer system IDE study results published
Bluegrass Vascular Technologies has announced the publication of the results of its prospective, multicenter SAVE-US (Surfacer system to facilitate access in venous occlusions—United States)...
COVID-19 survey: Support of hospitals and societies ‘paramount’ to promoting well-being...
Responses to the COVID-19 pandemic practice, anxiety, coping and support survey for vascular surgeons, recently presented in a Special Scientific Session on COVID-19 during SVS ONLINE on June...
French study: Third-gen Anaconda endograft indicates satisfactory five-year exclusion
The third-generation Anaconda endograft from Terumo Aortic provides “high technical success” as well as “satisfactory” five-year aneurysm exclusion and clinical success rates, a French multicenter prospective observational study has...
Women are at a higher risk of iliac vein stent failure,...
A recent study on iliac vein stenting showed lower long-term patency rates for women when compared to their male counterparts. The data were presented...
Study: Sirolimus-eluting balloon is a valid treatment for vasculogenic erectile dysfunction
A sirolimus-eluting balloon has been shown to be effective and safe for the treatment of vasculogenic erectile dysfunction (ED) in a first-in-man study presented...
MHRA: Warning to be added to paclitaxel device IFUs in Europe
In a new field safety notice, the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) states that a warning and clinical summary section will be...
CX 2020 LIVE: Vascular access session showcases new technologies, debate on...
The CX 2020 LIVE Vascular Access Consensus session sparked global interest, with chair Nick Inston (Birmingham, UK) and moderator Domenico Valenti (London, UK) taking questions...
CX 2020 LIVE aortic arch discussion highlights importance of underlying pathology...
Last week, the CX 2020 LIVE agenda turned to the technically challenging topic of aortic arch interventions. Through presentations, discussion, and polling, the session—chaired...
Nearly 70% of CX 2020 LIVE global aortic audience finds type...
A global audience tuned into the second session and inaugural aortic offering of CX 2020 LIVE. With registrations now well over 4,000, the pioneering virtual...
Researchers: No benefit for doxycycline used to avoid surgery for AAA
A new study by researchers at the University of Maryland School of Medicine in Baltimore found that patients with an abdominal aortic aneurysm (AAA)...
CX 2020 LIVE pioneers virtual vascular conference format in COVID-19 era
CX 2020 LIVE came to life online—despite COVID-19—using state-of-the art broadcast technology to bring together more than 1,000 vascular specialists, live, from 95 countries across...
Study cites drop in aortic dissection cases in NY during pandemic
In a recently-published study, researchers found a significant drop in acute aortic dissection cases in New York City since the beginning of the COVID-19 pandemic.
The study—”The...
AHA issues call to action to prevent VTE in hospitalised patients
Venous thromboembolism (VTE) is the leading cause of preventable hospital death in the U.S. and worldwide. A new policy statement from the American Heart...
Positive two-year data from ALPS registry of LimFlow system published
LimFlow SA today announced publication of positive two-year data from the ALPS registry of the LimFlow percutaneous deep vein arterialization (pDVA) system. Results were published...
TOBA III clinical trial results published
Intact Vascular has announced the peer-reviewed publication of its Tack optimized balloon angioplasty (TOBA) III 12-month clinical trial results in the Journal of Vascular Surgery.
The multi-center, single-arm,...
VIVA Physicians publishes analysis evaluating mortality and paclitaxel-coated devices
An individual patient-level data (IPD) analysis of the safety of paclitaxel-containing devices (PTXD), conducted by VIVA Physicians, identified an absolute 4.6% increased mortality risk...
Terumo Aortic gains FDA approval for Treo endovascular device
Terumo Aortic has been granted Food and Drug Administration (FDA) approval for the Treo abdominal aortic stent-graft system to be sold in the U.S.
The...
COVER study aims to capture impact of COVID-19 on global vascular...
The COVID-19 vascular service (COVER) study, a multinational, prospective, observational study that is aimed at capturing the impact of the pandemic on global vascular...
CMS outlines recommendations for re-starting non-emergent procedures
On 18 March, the Centers for Medicare & Medicaid Services (CMS) recommended “limiting non-essential care and expanding surge capacity into ambulatory surgical centers and...
Global vascular community addresses geographic disparity in COVID-19 impact and response
LONDON—Last week, the Charing Cross (CX) Symposium 2020 would have taken place in the U.K. capital. To mark the occasion virtually, experts from across...
‘Excellent’ long-term results after EVAR using Endurant stent graft in 180...
Results from a real-world experience over more than 10 years using the Endurant stent graft (Medtronic) demonstrate that it is safe and effective,...
First US commercial use of Tack Endovascular System in BTK arteries...
Intact Vascular has announced the first commercial use of its Tack Endovascular System (4F) in multiple sites across the United States.
Notably the first Food...
FDA grants Nexus aortic arch stent graft system breakthrough designation
Endospan was recently granted breakthrough device designation from the Food and Drug Administration (FDA) for the Nexus aortic arch stent graft system.
The FDA’s breakthrough...
First patient enrolled globally in SELUTION SLR study for AV fistulae
The objectives of this prospective, randomized, single-blind multicenter study are to demonstrate the safety and efficacy of SELUTION SLR in the treatment of failed...
CMSS urges strong action ‘to ensure safer working conditions’ for frontline...
In a new statement published on April 2, 2020, all 45 societies represented by the Council of Medical Specialty Societies (CMSS)—over 800,000 physicians—emphatically declared their...
Clopidogrel exposure along with aspirin and rivaroxaban should be ‘minimized or...
“More bleeding with background clopidogrel, even if not severe by adjudication, may be associated with broad consequences, including discontinuation of therapies. In the absence...
STABLE II results published on endovascular treatment of acute complicated TBAD...
Thirty-day and one-year data from the STABLE II study have been published in the April 2020 issue of the Journal of Vascular Surgery (JVS) by Joseph V....
American College of Surgeons releases new clinical guidance document for elective...
The American College of Surgeons (ACS) has issued guidance for surgeons to curtail recommendations for elective surgical procedures to preserve the necessary resources for...
Straub Medical announces first patient treated in US with Rotarex S...
Straub Medical, the US direct-sales subsidiary of Swiss outfit Straub Medical AG, has announced the launch and first intervention performed with the Rotarex S...
NICE aortic guidelines recommend discussion between physician and patient before offering...
The U.K. National Institute for Health and Care Excellence (NICE) has today published guidelines on abdominal aortic aneurysm (AAA) diagnosis and management. Discussion between...
National Kidney Foundation releases guideline for vascular access in dialysis patients
The American Journal of Kidney Diseases (AJKD) has published the National Kidney Foundation’s KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update, a completely revamped set...
New meta-analysis finds ‘no observed difference’ in mortality between paclitaxel and...
February 2020 brings another paclitaxel device meta-analysis of randomized controlled trials in chronic limb-threatening ischemia (CLTI) patients. Krystal Dinh, BMed, of Westmead Hospital, Sydney,...
SVS and STS release new reporting standards for type B aortic...
The Society for Vascular Surgery (SVS) and the Society of Thoracic Surgeons (STS) have released new reporting standards to ensure patients with type B...
Hotly-contested meta-analysis suggests a higher risk of death or amputation at...
A new meta-analysis, just published in the Journal of Vascular and Interventional Radiology (JVIR), suggests significantly reduced amputation-free survival at one year when paclitaxel-coated...
Regulatory unity can help drive medical device adoption globally, FDA official...
LAS VEGAS—Efforts at international collaboration across borders can drive harmony among disparate regulatory requirements and lead to greater global cooperation at the medical device...
Regulatory unity can help drive medical device adoption globally, FDA official...
LAS VEGAS—Efforts at international collaboration across borders can drive harmony among disparate regulatory requirements and lead to greater global cooperation at the medical device...